Our speaker programmes are carefully researched each year to ensure that delegates are exposed to the highest level of expertise. However, delegates not only benefit from the experience of our speakers, but also gain an insight into the experiences of other attendees – Q&A sessions and panel discussions are utilised to enable sharing of knowledge and facilitate idea exchange.

If you have a cutting edge case study or relevant presentation and would like to join the speaker panel at one of our events, please contact Eszter Sutowski-Nagy at [email protected]

Confirmed Speakers 2017 Include:

Joël Richard, Senior Vice President, Peptides, Head of CMC Development Dreux Site
Ipsen

Lotte Bjerre Knudsen, Scientific Vice President and Senior Principal Scientist
Novo Nordisk A/S

Lutz Jermutus, Senior Director, Product Development Team Leader, Cardiovascular & Metabolic Diseases iMED
MedImmune

Edwin Romijn, Associate Director NMR/MS
Janssen

Eric Valeur, Associate Director New Modalities
AstraZeneca

Michael Wagner, Head of Insulins & Peptides
Sanofi-Aventis Deutschland GmbH

Graham Simpson, Head of Therapeutic Peptide CPU
GlaxoSmithKline

Anouk Dirksen, Senior Principal Scientist, Group Leader and Technology Lead
Pfizer

Christoph Dumelin, Platform Lead and Investigator
Novartis

Ana dos Santos, Principal Scientist
MedImmune

Jarek Juraszek, Principal Scientist
Janssen

Gilles Goetz, Principal Scientist, Analytical Chemistry
Pfizer

Suzanne M. D’Addio, Associate Principal Scientist, Formulation Science
Merck Sharp & Dohme

Stephanie Gueret, Senior Research Scientist
AstraZeneca

Jameson Bothe, Senior Scientist
Merck Sharp & Dohme

Johanna Mora, Senior Research Investigator
Bristol-Myers Squibb

Adam Mezo, Senior Research Advisor and Group Leader, Peptide Chemistry
Eli Lilly and Company

Patrick Jimonet, External Innovation & Sourcing, Lead Generation to Candidate Realization
Sanofi R&D

Mark Currie, Senior Vice President, Chief Scientific Officer and President of R&D
Ironwood Pharmaceuticals

Steffen Weinbrenner, Head of Drug Discovery
Polyphor

David Hardick, Group Leader, Discovery Chemistry
Bicycle Therapeutics

Ashok Bhandari, Vice President, Chemistry
Protagonist Therapeutics

Mette Svendgaard, Director, Pharmaceutical Development
Zealand Pharma

Rie Schultz Hansen, Principal Scientist
Zealand Pharma

Annemieke Madder, Professor
University of Ghent

Sandrine Ongeri, Professor
University of Paris-Sud

Ülo Langel, Professor
Stockholm University

Timo Müller, Associate Director & Head of Division of Molecular Pharmacology
Helmholtz Zentrum München